Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Theravance Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −2 vs. Q3 2021
- Shares held
- 59.3M
- −1.22M (−2.0%) vs. Q3 2021
- Total value
- $655.6M
- +$207.5M (+46.3%) vs. Q3 2021
- New holders
- 21
- 50 more added
- Sold out
- 23
- 28 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 179 | $817.5M |
| Q1 2026 | 173 | $814.2M |
| Q4 2025 | 169 | $927.2M |
| Q3 2025 | 161 | $706.3M |
| Q2 2025 | 135 | $512.2M |
| Q1 2025 | 132 | $400.9M |
| Q4 2024 | 128 | $422.4M |
| Q3 2024 | 119 | $368.9M |
| Q2 2024 | 132 | $399.5M |
| Q1 2024 | 121 | $430.6M |
| Q4 2023 | 118 | $548.7M |
| Q3 2023 | 115 | $438.5M |
| Q2 2023 | 119 | $546.3M |
| Q1 2023 | 114 | $652.6M |
| Q4 2022 | 119 | $696.1M |
| Q3 2022 | 123 | $649.8M |
| Q2 2022 | 113 | $582.0M |
| Q1 2022 | 121 | $602.5M |
| Q4 2021 | 116 | $655.6M |
| Q3 2021 | 119 | $448.8M |
| Q2 2021 | 109 | $883.1M |
| Q1 2021 | 107 | $1.09B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 614,361 | $6.79M | 0.00% | +11,723+1.9% | Added |
| Tekla Capital Management LLC | 656,296 | $7.25M | 0.23% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 876,463 | $9.68M | 0.01% | +456,412+108.7% | Added |
| Newtyn Management, LLC | 1,000,000 | $11.1M | 2.93% | +902,045+920.9% | Added |
| Jacobs Levy Equity Management, Inc | 1,022,928 | $11.3M | 0.08% | +377,051+58.4% | Added |
| Geode Capital Management, LLC | 1,041,832 | $11.5M | 0.00% | +346,328+49.8% | Added |
| Chescapmanager LLC | 1,261,674 | $13.9M | 2.12% | −630,778−33.3% | Reduced |
| State Street Corp | 1,360,202 | $15.0M | 0.00% | −12,045−0.9% | Reduced |
| Morgan Stanley | 1,479,029 | $16.3M | 0.00% | +950,477+179.8% | Added |
| FMR LLC | 2,588,381 | $28.6M | 0.00% | −82,500−3.1% | Reduced |
| Weiss Asset Management LP | 2,601,778 | $28.8M | 0.67% | +2,601,778 | New |
| BlackRock Inc. | 5,002,363 | $55.3M | 0.00% | −102,096−2.0% | Reduced |
| OrbiMed Advisors LLC | 5,974,535 | $66.0M | 0.86% | +79,376+1.3% | Added |
| Vanguard Group Inc | 6,299,823 | $69.6M | 0.00% | +443,268+7.6% | Added |
| Madison Avenue Partners, LP | 6,648,025 | $73.5M | 15.90% | +1,718,602+34.9% | Added |
| Baupost Group LLCSuperinvestorBaupost Group | 13,660,168 | $150.9M | 1.49% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −687,500−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −577,800−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −129,192−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −62,546−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −53,127−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −34,000−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −27,200−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −27,095−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −24,799−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,958−100.0% | Sold out |
| Palisade Capital Management LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,482−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −14,721−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,791−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −13,516−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −12,649−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,685−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −775−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −352−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Kowal Investment Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Zazove Associates LLC | – | – | – | – | Not filed |